ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 143

$835K Total Retail Price of All Prescriptions

Rank: 6 out of 143

557 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,195 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
PRAVASTATIN SODIUM 609 549 1 9
ATORVASTATIN CALCIUM 302 297 2 7
LEVOTHYROXINE SODIUM 298 281 3 3
AMLODIPINE BESYLATE 246 240 4 4
LISINOPRIL 209 192 5 1
METFORMIN HCL 165 149 6 8
OMEPRAZOLE 165 154 6 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 142 8 21
ATENOLOL 135 128 9 11
ZOLPIDEM TARTRATE 133 128 10 13
CRESTOR 131 95 11 17
CITALOPRAM HBR 123 117 12 25
TAMSULOSIN HCL 114 109 13 28
FUROSEMIDE 104 85 14 6
ALLOPURINOL 98 98 15 39
TRAMADOL HCL 87 73 16 16
GLIMEPIRIDE 87 74 16 27
CARVEDILOL 85 80 18 22
DIOVAN 81 71 19 26
METOPROLOL SUCCINATE 80 74 20 14
DIOVAN HCT 79 76 21 60
LUNESTA 75 61 22 188
LOSARTAN-HYDROCHLOROTHIAZIDE 73 71 23 52
FAMOTIDINE 72 72 24 98
HYDROCHLOROTHIAZIDE 71 60 25 10
LIPITOR 71 71 25 57
NEXIUM 65 56 27 32
WARFARIN SODIUM 61 57 28 15
METOPROLOL TARTRATE 60 56 29 12
CYMBALTA 59 50 30 47
PANTOPRAZOLE SODIUM 58 50 31 43
CLOPIDOGREL 57 50 32 33
ONGLYZA 56 45 33 210
DIGOXIN 54 50 34 71
BUPROPION XL 53 53 35 88
FINASTERIDE 50 50 36 97
CLONIDINE HCL 50 37 36 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.